Addex Therapeutics (ADXN) vs Lunai Bioworks (LNAI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Addex Therapeutics is the larger company by market cap ($5.4 million vs $5.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ADXN | LNAI |
|---|---|---|
| Share price | $3.11 | $1.12 |
| Market cap | $5.44M | $5.08M |
| 1-day change | +4.29% | +2.75% |
| EPS (TTM) | $-7.56 | $-61.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.97 | $13.28 |
| 52-week low | $2.56 | $1.08 |
| Distance from 52-week high | -74.06% | -91.57% |
| Average volume | 138.01K | 181.37K |
| Shares outstanding | 1.75M | 4.53M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ADXN vs LNAI FAQ
Which is bigger, Addex Therapeutics or Lunai Bioworks?
Addex Therapeutics (ADXN) is larger, with a market capitalization of $5.44M compared with $5.08M for Lunai Bioworks (LNAI).
Are Addex Therapeutics and Lunai Bioworks in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.